ONO-3951 Phase II Study
Phase 2
- Conditions
- Irritable bowel syndrome with diarrhea(IBS-D)
- Registration Number
- JPRN-jRCT2080221823
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
1. Subjects diagnosed with IBS-D based on the Rome III diagnostic criteria
Exclusion Criteria
1. Presence or history of any of the organic gastrointestinal diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method